American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Cuker, Adam; Tseng, Eric; Nieuwlaat, Robby; Angchaisuksiri, Pantep; Blair, Clifton; Dane, Kathryn; Davila, Jennifer; T. DeSancho, Maria; Diuguid, David; O. Griffin, Daniel; R. Kahn, Susan; A. Klok, Frederikus; Ian Lee, Alfred; Neumann, Ignacio; Pai, Ashok; Pai, Menaka; Righini, Marc; M. Sanfilippo, Kristen; Siegal, Deborah; Skara, Mike; Touri, Kamshad; A. Akl, Elie; Bou Akl, Imad; Boulos, Mary; Brignardello‐Petersen, Romina; Charide, Rana; T.V. Chan, Matthew; Dearness, Karin; Darzi, Andrea; Kolb, Philipp; Enrique Colunga‐Lozano, Luis; Mansour, Razan; Paolo Morgano, Gian; Z. Morsi, Rami; Noori, Atefeh; Piggott, Thomas; Qiu, Yuan; Roldán, Yetiani; Schünemann, Finn; Stevens, Adrienne; Solo, Karla; Ventresca, Matthew; Wiercioch, Wojtek; A. Mustafa, Reem; J. Schünemann, Holger

doi:10.1182/bloodadvances.2020003763

Public

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Published in Blood Advances • Feb 8, 2021

Authors:

Adam Cuker

Eric Tseng

Robby Nieuwlaat

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19)-related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE). OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health...

Subject

Medicine

Guideline

Intensive care medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!